Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
The findings in this whitepaper demonstrate that early detection and intervention are critical in addressing the rising rates of undiagnosed heart valve disease.
Can coronary artery disease be detected early by including a polygenic risk assessment?
A trial on the prevention of heart failure for people who have risk factors for developing heart failure.
Baker Institute researchers are embarking on a randomised controlled trial to see how exercise rehabilitation might support people suffering from long Covid following an observational study indicating that it seems to be effective.
Benefits for type 2 diabetes of interrupting prolonged sitting.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
Imaging athletes’ hearts during exercise, not at rest.
Biomarkers that highlight toxic fats in the liver.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more